Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
2006

Cyclin A1 Methylation in Cervical Cancer

Sample size: 122 publication Evidence: high

Author Information

Author(s): Kitkumthorn Nakarin, Yanatatsanajit Pattamawadee, Nuchjoe, Kiatpongsan Sorapop, Phokaew Chureerat, Triratanachat Surang, Trivijitsilp Prasert, Termrungruanglert Wichai, Tresukosol Damrong, Niruthisard Somchai, Mutirangura Apiwat

Primary Institution: Chulalongkorn University

Hypothesis

The study aims to evaluate the epigenetic status of cyclin A1 in human papillomavirus-associated cervical cancer.

Conclusion

Cyclin A1 promoter hypermethylation is common in cervical cancer and may serve as a potential tumor marker for early diagnosis of invasive cervical cancer.

Supporting Evidence

  • Cyclin A1 methylation was found in 93.3% of invasive cervical cancers.
  • No methylation was observed in normal cervical tissues or low-grade lesions.
  • The study suggests that cyclin A1 methylation occurs earlier than morphological changes in cervical cancer.

Takeaway

This study found that a specific change in a gene called cyclin A1 is very common in cervical cancer, which could help doctors find this type of cancer earlier.

Methodology

The study used duplex methylation-specific PCR and reverse transcriptase PCR on cervical cancer cell lines and tissue samples.

Digital Object Identifier (DOI)

10.1186/1471-2407-6-55

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication